3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
25
Neoplasm Metastasis
11
Stomach Neoplasms
6
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Colorectal Neoplasms
4
Salivary Gland Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Neoplasms
2
Advanced Breast Cancer
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
12
Cisplatin
9
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
Radiotherapy, Intensity-Modulated
6
Cetuximab
6
Biopsy
6
Radiation
5
Carboplatin
5
Radiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
X-Rays
3
Taxes
3
Standard of Care
3
Paclitaxel
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Ultrasonography
2
Practice Guidelines as Topic
2
Optical Imaging
2
Interviews as Topic
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
trastuzumab deruxtecan
×
90 days
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled